Phase III clinical trial - Prostate

PRESTO (GETUG-AFU 36)

Prostate

Ouvert depuis le: 07.27.2024

Site: Paris

Public cible

Adulte

Prostate-cancer treatment using stereotactic radiotherapy for oligometastases;ablation in hormone-sensitive patients À a GETUG-AFU phase III randomized controlled trial

Description de l'essai

To assess the efficacy of ablative radiotherapy (SBRT applied to all;oligometastases) administered to all gross tumor sites (metastases +/- prostate), in oligometastatic;hormone-sensitive prostate cancer patients.